Thursday, 19th November COSA 2015 ASM

COSA Breakfast session

Speaker: Leeka Kheifets 

Mobile phones were first marketed for commercial use some thirty years ago, and while initially, cell phone use was uncommon, in the decades that followed mobile phones evolved into an everyday necessity for much of the world’s population. They are no longer simple devices for voice calls, but rather, they affect nearly every aspect of human life and culture. They have become a pervasive part of our society, and between 2000 and 2014, the number of active mobile phone subscriptions increased from 700 million to nearly 7 billion globally. Advances in mobile phone technology and availability have brought with them many advantages, including greater access to communication, information, and economic development and an astonishing array of resources to address almost any need or interest.  

While there are  many benefits of this technology, there remain questions about its safety. Despite limited scientific evidence, the rapid growth of this exposure over a relatively short time in combination with  a large public concern and the potential for major consequences presents a policy challenge. Come and learn about exposures from mobile phones and wifi technologies, what we know about potential health effects, including brain cancer, and what we can do about it. A broad range of scientific viewpoints and industry pressure give the debate a sharp edge, particularly when it comes to  mobile phone use by children.     

Speakers: TBC

Content: This early career researcher (ECR) mentoring breakfast will give participants the opportunity to talk with leading researchers and clinicians. Small groups will meet with a mentor to discuss ECR issues including how to plan a career in research, establishing yourself as an independent researcher and maximising the impact of your research. The small group format allows the opportunity for relevant and specific advice. This is a great opportunity to share ideas with an expert in the field and to network with other ECRs.

• Interventional oncology: an indispensable part of modern cancer care - Andreas Adam
• Vaccines and immunotherapy - Poulam M Patel
• Pharma: Developing Drugs at the Speed of Need - Dan Mellor
• Tumour mutation testing – challenges and opportunities in rare cancers - Sandra O'Toole

• Partnering molecular pathology and genotyping to enable precision targeting in sarcoma - Brian O'Sullivan
• Targeted therapies for triple negative breast cancer - Heather Cunliffe
• From xenografts to the clinic: modelling new therapies in bladder cancer - Derek Raghavan
• Keeping the faith: targeted therapies in advanced renal cell carcinoma - Carmel Pezaro

• A patient’s perspective of harms - Luke Ryan
• Is personalised medicine delivering on the promise of reduced drug-related harm - Christine Carrington
• Harms of treatment: Cardiotoxicity - Tom Marwick
• Psychological approaches to working with people with cancer and their families: Not just anxiety and depression. - Annabel Pollard
• Whose harm is it anyway? The many ethical dimensions of harm in healthcare - Jennifer Morris

• Designing new systems of care to deliver value based health care - Jim Bishop
• Redesigning care: The challenges and opportunities of funding cancer care - Terry Symonds
• The potential of Integrated Practice Units to add value to cancer care - feasible or folly? - David Speakman

• The attitudes, beliefs and behaviours of health care professionals regarding dietary supplements - Wolfgang Marx
• When a cancer patient in the waiting room is a rarity: Development of an oncology specific resource to support generalist private practice and community dietitians across Australia - Anna Boltong
• Designing complex interventions to translate research into practice: A rare but important opportunity for nutrition care - Merran Findlay
• No risk of gastric cancer but nutritional risks aplenty - Belinda Steer

• Lynch syndrome: The Greatest Story Never Told - Susan Morris
• Lynch Syndrome screening by antibody alone - Nicholas J Hawkins
• Translating Basic Research into the Clinical Management of Families with Lynch Syndrome - Mathew Sloane
• Achieving healthcare professional behaviour change for detection and management of Lynch syndrome - Natalie Taylor
• At risk and unreachable - Implementing the Family Communication Tool into the clinic to improve dissemination of information. - Kathy Tucker

Mark Dawson: Cancer Epigenetics: The journey from concept to therapy

Panel Members TBC